Thirumalai Chemicals profit and loss

Latest FY26

Revenue: ₹1,736cr−15.3% on FY25
EBITDA: −₹35.2cr₹48.8 cr in FY25
Net profit: −₹168cr−₹46.1 cr in FY25
EPS: −₹14.91−₹4.50 in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,832	1,736	2,050	2,083	2,132	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	24.0	18.7	20.6	19.3	30.2
	1,856	1,754	2,070	2,102	2,162
	1,396	1,335	1,553	1,670	1,516
	20.3	17.7	46.6	16.1	2.6
	−10.8	14.9	−12.7	−22.1	12.6
	84.0	87.8	88.5	79.8	78.7
	123	89.0	49.2	41.7	31.3
	89.7	88.4	61.1	63.2	55.7
	322	315	326	288	336
	2,025	1,948	2,111	2,137	2,033
	20.0	−35.2	48.8	51.0	186
	−69.7	−124	−12.3	−12.2	131
Profit
	−169	−194	−40.9	−34.6	129
	−8.0	−8.0	0.0	0.0	0.0
	−177	−202	−40.9	−34.6	129
	−3.1	−3.1	22.1	11.1	37.9
	−21.8	−30.8	−16.9	−6.8	1.7
	−24.9	−33.9	5.3	4.2	39.6
	−152	−168	−46.1	−38.8	89.8
	−152	−168	−46.1	−38.8	89.8
	78.7	80.4	65.8	8.4	42.7
	−72.9	−87.6	19.7	−30.4	133
	—	—	—	−38.8	89.8
Per share
	−₹12.93	−₹14.91	−₹4.50	−₹3.79	₹8.77
	−₹12.93	−₹14.91	−₹4.50	−₹3.79	₹8.77
Other comprehensive income — detail
	78.7	80.4	65.8	—	—
	−48.5	−45.1	60.3	1.0	0.2
	−4.5	−6.5	9.5	—	—
	123	119	15.1	7.5	42.5
Per share — as-filed variants
	−₹12.93	−₹14.91	−₹4.50	−₹3.79	₹8.77
	−₹12.93	−₹14.91	−₹4.50	−₹3.79	₹8.77
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	426	368	463	419	601
	23.3%	21.2%	22.6%	20.1%	28.2%
Adjusted (ex-exceptional items) — derived
	−169	−194	−40.9	−34.6	129
	−8.0	−8.0	0.0	0.0	0.0
	−145	−161	−46.1	−38.8	89.8
	−₹12.35	−₹14.32	−₹4.50	−₹3.79	₹8.77

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

TIRUMALCHM₹119.82

Thirumalai Chemicals Limited

· Chemicals

Annual Quarterly₹ CrorePeersPAUSHAKLTD DEEPAKNTR FACT CLEAN CAMLINFINE VIDHIING BAYERCROP JUBLINGREAMcap ₹1,445 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	2,132.2	2,083.1	2,049.5	1,735.5	1,832.1
Other Income	30.2	19.3	20.6	18.7	24.0
Total Income	2,162.4	2,102.5	2,070.1	1,754.2	1,856.1
Expenses
+ Cost of Materials Consumed	1,515.9	1,670.0	1,552.8	1,335.0	1,396.4
+ Purchases of Stock-in-Trade	2.6	16.1	46.6	17.7	20.3
+ Changes in Inventories	12.6	-22.1	-12.7	14.9	-10.8
+ Employee Benefit Expense	78.7	79.8	88.5	87.8	84.0
+ Finance Costs	31.3	41.7	49.2	89.0	122.8
+ Depreciation & Amortisation	55.7	63.2	61.1	88.4	89.7
+ Other Expenses	336.2	288.3	325.5	315.2	322.1
Total Expenses	2,033.0	2,137.0	2,111.0	1,948.0	2,024.6
EBITDA	186.2	51.0	48.8	-35.2	20.0
EBIT	130.5	-12.2	-12.3	-123.5	-69.7
Profit
PBT before Exceptional Items	129.4	-34.6	-40.9	-193.8	-168.5
+ Exceptional Items	0.0	0.0	0.0	-8.0	-8.0
Pretax Income	129.4	-34.6	-40.9	-201.8	-176.5
+ Current Tax	37.9	11.1	22.1	-3.1	-3.1
+ Deferred Tax	1.7	-6.8	-16.9	-30.8	-21.8
Tax Expense	39.6	4.2	5.3	-33.9	-24.9
Net Income	89.8	-38.8	-46.1	-167.9	-151.6
+ Net Income — Continuing Ops	89.8	-38.8	-46.1	-167.9	-151.6
+ Other Comprehensive Income	42.7	8.4	65.8	80.4	78.7
Total Comprehensive Income	132.5	-30.4	19.7	-87.6	-72.9
Net Income to Common	89.8	-38.8	—	—	—
Per Share
Basic EPS	8.77	-3.79	-4.50	-14.91	-12.93
Diluted EPS	8.77	-3.79	-4.50	-14.91	-12.93
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	65.8	80.4	78.7
+ Items NOT to be Reclassified to P&L	0.2	1.0	60.3	-45.1	-48.5
+ Tax on Items NOT to be Reclassified	—	—	9.5	-6.5	-4.5
+ Items to be Reclassified to P&L	42.5	7.5	15.1	119.0	122.7
Per Share — as-filed variants
Basic EPS — Continuing Operations	8.77	-3.79	-4.50	-14.91	-12.93
Diluted EPS — Continuing Operations	8.77	-3.79	-4.50	-14.91	-12.93
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	601.1	419.1	462.8	367.9	426.2
Gross Margin %	28.19	20.12	22.58	21.20	23.26
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	129.4	-34.6	-40.9	-193.8	-168.5
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-8.0	-8.0
Net Income Adj (tax-effected)	89.8	-38.8	-46.1	-161.3	-144.8
EPS Adj	8.77	-3.79	-4.50	-14.32	-12.35
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	10.2	10.2	10.2	12.1	12.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.